Cargando…

351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago

BACKGROUND: Neurocysticercosis is a major cause of adult-onset epilepsy and premature death in adults. We aimed to describe the clinical and demographic features in a large patient population in Chicago of which published data is limited. METHODS: A retrospective chart search with ICD9/ICD10 diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pendyala, Bharath, Lingamaneni, Prasanth, DeMarais, Patricia, Warrior, Lakshmi, Huhn, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776615/
http://dx.doi.org/10.1093/ofid/ofaa439.546
_version_ 1783630724651286528
author Pendyala, Bharath
Lingamaneni, Prasanth
DeMarais, Patricia
Warrior, Lakshmi
Huhn, Gregory
author_facet Pendyala, Bharath
Lingamaneni, Prasanth
DeMarais, Patricia
Warrior, Lakshmi
Huhn, Gregory
author_sort Pendyala, Bharath
collection PubMed
description BACKGROUND: Neurocysticercosis is a major cause of adult-onset epilepsy and premature death in adults. We aimed to describe the clinical and demographic features in a large patient population in Chicago of which published data is limited. METHODS: A retrospective chart search with ICD9/ICD10 diagnostic code for Neurocysticercosis and neuroimaging suggestive of Neurocysticercosis was performed for clinical encounters in the hospital or affiliated clinics between 2013–2018. After a careful chart review, patients who were clinically diagnosed with Neurocysticercosis were included in the study. A descriptive analysis of the data is presented. RESULTS: Out of a total of 90 patients all of whom were immigrants, the country of origin was reported in 60% and the majority were from Mexico (83.3%). The mean age at the time of diagnosis was 32.3 years (median 29.5, range < 1 to 67). The most common presenting complaints were seizures (62.1%) and headache (27.6%). The most common type of seizure was generalized (48.8%) followed by focal (36.6%). Approximately a third of patients also had hydrocephalus (33.7%). Many patients had > 1 lesion on neuroimaging (70.7%) out of which the most common type were parenchymal lesions (60.9%) followed by ventricular and subarachnoid. Calcified (45.5%) and cystic lesions (44.2%) were found in about equal number of cases. A minority had both types of lesions (10.4%). Contrast enhancement or edema surrounding the lesion was found in about half (47.2%) of the cases. The number of years since the last visit to an endemic country before diagnosis was reported in 46.6% of cases and the mean was 9.8 years (range 0 to 30) and it was found that per year increase since the last visit increased the chance of having contrast enhancement/edema surrounding the lesion in neuroimaging or requiring treatment with antiparasitic medications. (OR 1.77 (1.08–2.90), P= 0.03). CONCLUSION: Our study agrees with previously reported data regarding seizure being the most common presenting complaint, generalized seizures being the most common type. The increasing risk of active lesions with increasing duration since the last visit to an endemic country raises the concern of clinically consequential delay in diagnosis. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776615
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77766152021-01-07 351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago Pendyala, Bharath Lingamaneni, Prasanth DeMarais, Patricia Warrior, Lakshmi Huhn, Gregory Open Forum Infect Dis Poster Abstracts BACKGROUND: Neurocysticercosis is a major cause of adult-onset epilepsy and premature death in adults. We aimed to describe the clinical and demographic features in a large patient population in Chicago of which published data is limited. METHODS: A retrospective chart search with ICD9/ICD10 diagnostic code for Neurocysticercosis and neuroimaging suggestive of Neurocysticercosis was performed for clinical encounters in the hospital or affiliated clinics between 2013–2018. After a careful chart review, patients who were clinically diagnosed with Neurocysticercosis were included in the study. A descriptive analysis of the data is presented. RESULTS: Out of a total of 90 patients all of whom were immigrants, the country of origin was reported in 60% and the majority were from Mexico (83.3%). The mean age at the time of diagnosis was 32.3 years (median 29.5, range < 1 to 67). The most common presenting complaints were seizures (62.1%) and headache (27.6%). The most common type of seizure was generalized (48.8%) followed by focal (36.6%). Approximately a third of patients also had hydrocephalus (33.7%). Many patients had > 1 lesion on neuroimaging (70.7%) out of which the most common type were parenchymal lesions (60.9%) followed by ventricular and subarachnoid. Calcified (45.5%) and cystic lesions (44.2%) were found in about equal number of cases. A minority had both types of lesions (10.4%). Contrast enhancement or edema surrounding the lesion was found in about half (47.2%) of the cases. The number of years since the last visit to an endemic country before diagnosis was reported in 46.6% of cases and the mean was 9.8 years (range 0 to 30) and it was found that per year increase since the last visit increased the chance of having contrast enhancement/edema surrounding the lesion in neuroimaging or requiring treatment with antiparasitic medications. (OR 1.77 (1.08–2.90), P= 0.03). CONCLUSION: Our study agrees with previously reported data regarding seizure being the most common presenting complaint, generalized seizures being the most common type. The increasing risk of active lesions with increasing duration since the last visit to an endemic country raises the concern of clinically consequential delay in diagnosis. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776615/ http://dx.doi.org/10.1093/ofid/ofaa439.546 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Pendyala, Bharath
Lingamaneni, Prasanth
DeMarais, Patricia
Warrior, Lakshmi
Huhn, Gregory
351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
title 351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
title_full 351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
title_fullStr 351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
title_full_unstemmed 351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
title_short 351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
title_sort 351. neurocysticercosis: clinical experience in large urban safety net hospital in chicago
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776615/
http://dx.doi.org/10.1093/ofid/ofaa439.546
work_keys_str_mv AT pendyalabharath 351neurocysticercosisclinicalexperienceinlargeurbansafetynethospitalinchicago
AT lingamaneniprasanth 351neurocysticercosisclinicalexperienceinlargeurbansafetynethospitalinchicago
AT demaraispatricia 351neurocysticercosisclinicalexperienceinlargeurbansafetynethospitalinchicago
AT warriorlakshmi 351neurocysticercosisclinicalexperienceinlargeurbansafetynethospitalinchicago
AT huhngregory 351neurocysticercosisclinicalexperienceinlargeurbansafetynethospitalinchicago